MedTrace Logo

Delayed Diagnostic Time& Inflammatory Bowel Diseased Patients

NCT04952558 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2021-07-07

No results posted yet for this study

Summary

Introduction The incidence of inflammatory bowel disease \[IBD\] is increasing worldwide. Both Crohn's disease \[CD\] and ulcerative colitis \[UC\] are therefore becoming an important public health issue\[1\] The IBD is characterized by chronic intestinal inflammation, which can cause bowel damage and intestinal complications primarily depending on the duration and severity of the inflammation\[2\] The diagnosis of inflammatory bowel diseases (IBD) is often established following considerable delay due to nonspecific and inconsistent symptoms. In previous western studies, the delayed diagnosis was associated with poor outcome in patients with Crohn's disease (CD).\[2\] Timely diagnosis is not only important for the patients themselves but has also become a relevant public health issue due to the rising incidence of IBD worldwide\[3\] Patients and methods Cross sectional observational study will be conducted among 700 patients of Egyptian inflammatory bowel diseased patients for different regions Aim of the study

1. Estimate time delay for diagnosis of Egyptian inflammatory bowel diseased patients
2. compare the delay time for diagnosis of Egyptian inflammatory bowel diseased patients globally

Conditions

  • Inflammatory Bowel Diseases

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-01-01
Completion
2022-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04952558 on ClinicalTrials.gov